- Home
- IGC vs CLGN Comparison
IGC vs CLGN Comparison
Compare IGC & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- CLGN
- Stock Information
- Founded
- IGC 2005
- CLGN 2004
- Country
- IGC United States
- CLGN Israel
- Employees
- IGC N/A
- CLGN N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- CLGN Industrial Specialties
- Sector
- IGC Health Care
- CLGN Health Care
- Exchange
- IGC Nasdaq
- CLGN Nasdaq
- Market Cap
- IGC 39.8M
- CLGN 33.8M
- IPO Year
- IGC N/A
- CLGN N/A
- Fundamental
- Price
- IGC $0.42
- CLGN N/A
- Analyst Decision
- IGC Strong Buy
- CLGN Strong Buy
- Analyst Count
- IGC 2
- CLGN 2
- Target Price
- IGC $4.00
- CLGN $11.50
- AVG Volume (30 Days)
- IGC 695.2K
- CLGN 252.2K
- Earning Date
- IGC 11-11-2025
- CLGN 11-26-2025
- Dividend Yield
- IGC N/A
- CLGN N/A
- EPS Growth
- IGC N/A
- CLGN N/A
- EPS
- IGC N/A
- CLGN N/A
- Revenue
- IGC $1,327,000.00
- CLGN $2,402,000.00
- Revenue This Year
- IGC $15.26
- CLGN $1,617.28
- Revenue Next Year
- IGC $3.41
- CLGN $83.54
- P/E Ratio
- IGC N/A
- CLGN N/A
- Revenue Growth
- IGC 24.95
- CLGN 248.62
- 52 Week Low
- IGC $0.25
- CLGN $1.31
- 52 Week High
- IGC $0.50
- CLGN $4.99
- Technical
- Relative Strength Index (RSI)
- IGC 52.73
- CLGN 39.17
- Support Level
- IGC $0.39
- CLGN $2.18
- Resistance Level
- IGC $0.43
- CLGN $3.18
- Average True Range (ATR)
- IGC 0.02
- CLGN 0.21
- MACD
- IGC -0.00
- CLGN -0.07
- Stochastic Oscillator
- IGC 44.42
- CLGN 3.00
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.